Balyasny Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Hold
0
1942
2025
Q1
Sell
-396,922
Closed -$7.28M 1958
2024
Q4
$7.28M Sell
396,922
-727,650
-65% -$13.4M 0.01% 751
2024
Q3
$17.3M Buy
1,124,572
+352,426
+46% +$5.42M 0.03% 506
2024
Q2
$12.5M Buy
+772,146
New +$12.5M 0.02% 574
2024
Q1
Sell
-300,875
Closed -$9.42M 1936
2023
Q4
$9.42M Buy
300,875
+284,557
+1,744% +$8.91M 0.02% 648
2023
Q3
$340K Buy
+16,318
New +$340K ﹤0.01% 1412
2023
Q1
Sell
-2,578
Closed -$41K 2139
2022
Q4
$41K Buy
+2,578
New +$41K ﹤0.01% 1934
2022
Q3
Sell
-10,390
Closed -$146K 2318
2022
Q2
$146K Buy
+10,390
New +$146K ﹤0.01% 1794
2022
Q1
Sell
-85,687
Closed -$2M 2073
2021
Q4
$2M Sell
85,687
-43,291
-34% -$1.01M 0.01% 1019
2021
Q3
$2.14M Buy
+128,978
New +$2.14M 0.01% 908
2020
Q4
Sell
-67,864
Closed -$2.8M 1109
2020
Q3
$2.8M Buy
67,864
+60,072
+771% +$2.48M 0.02% 593
2020
Q2
$378K Buy
+7,792
New +$378K ﹤0.01% 799
2019
Q1
Sell
-78,845
Closed -$1.28M 1264
2018
Q4
$1.28M Sell
78,845
-1,177,231
-94% -$19M 0.01% 740
2018
Q3
$26.1M Buy
1,256,076
+1,173,483
+1,421% +$24.4M 0.12% 211
2018
Q2
$1.26M Buy
+82,593
New +$1.26M 0.01% 895
2018
Q1
Sell
-357,958
Closed -$10.8M 1700
2017
Q4
$10.8M Buy
+357,958
New +$10.8M 0.03% 530
2017
Q3
Sell
-141,745
Closed -$3.95M 1628
2017
Q2
$3.95M Buy
+141,745
New +$3.95M 0.02% 654
2017
Q1
Sell
-432,691
Closed -$12.5M 1382
2016
Q4
$12.5M Buy
+432,691
New +$12.5M 0.07% 341
2016
Q2
Hold
0
958
2016
Q1
Hold
0
1037